Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Filtros aplicados
Base de dados
Intervalo de ano de publicação
1.
West Indian med. j ; 32(3): 191-3, Sept. 1983.
Artigo em Inglês | MedCarib | ID: med-11416

RESUMO

A case report of a 20-year-old woman who developed a stroke while on oral contraceptive therapy is presented. The report is intended to focus attention on an important, although infrequently considered, risk associated with the use of the birth control pill (AU)


Assuntos
Adulto , Feminino , Humanos , Embolia e Trombose Intracraniana/induzido quimicamente , Anticoncepcionais Orais/efeitos adversos , Anticoncepcionais Orais Sintéticos/efeitos adversos , Mestranol/efeitos adversos , Noretindrona/efeitos adversos , Jamaica
2.
Contraception ; 20(1): 29-48, July 1979.
Artigo em Inglês | MedCarib | ID: med-8032

RESUMO

To study the question of whether one brand of oral contraceptives may be as acceptable as another for use in publicly-assisted family planning programs, a double blind study of two well-known brands, Ovral and Norinyl, was undertaken in Costa Rica and Trinidad. The pills were randomly assigned to 1,200 women. Common side effects - nausea, dizziness, vomiting, headaches - were associated with both Norinyl and Ovral. Differences in event rates for these conditions were much more marked by country than by pill used. Ovral was associated with increases in skin problems, notably chloasma, in Costa Rica. A higher percentage of women using Norinyl reported intermentstral bleeding and spotting in both countries. In Costa Rica continuation rated for Norinyl were adversely affected by this. With these exceptions there appear to be no important differences between the brands that would affect their use in family planning programs (AU)


Assuntos
Humanos , Adolescente , Adulto , Feminino , Anticoncepcionais Orais , Anticoncepcionais Orais Combinados , Costa Rica , Método Duplo-Cego , /farmacologia , Mestranol/farmacologia , Noretindrona , Norgestrel/farmacologia , Trinidad e Tobago , Hemorragia Uterina/etiologia
3.
Curr Med Res Opin ; 1(1): 53-61, Mar. 1972.
Artigo em Inglês | MedCarib | ID: med-13328

RESUMO

503 women were given continuous treatment with norethisterone 0.35mg. (Noriday) daily for 2555 cycles. One pregnancy occured due to method failure, and four due to pill ommisions. The patients found continuous daily tablet taking easy to remember. During treatment they felt well and many recovered from side-effects experienced during previous medication on the conventional 'pill'. Changes occured in cycle characteristics during treatment, but the incidence of unwanted effects fell rapidly after the initial cycles. The inconvenience only caused a 5.2 percent withdrawal. Medical adverse reactions were notably absent and less than observed on the combined oestrogen/progestrogen pill, and 10 percent discontinued for purely social and unrelated causes. (AU)


Assuntos
Humanos , Gravidez , Feminino , Noretindrona/administração & dosagem , Peso Corporal , Reino Unido , Jamaica , Menstruação , Distúrbios Menstruais/induzido quimicamente , Nova Zelândia , Noretindrona/efeitos adversos , Noretindrona/farmacocinética , Fatores de Tempo , Hemorragia Uterina/induzido quimicamente
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...